NCT01210222 · Interventional trial
Trebananib in Treating Patients With Persistent or Recurrent Endometrial Cancer
Overall registry status Completed
Phase 2
Conditions Endometrial Adenocarcinoma, Endometrial Adenosquamous Carcinoma, Endometrial Clear Cell Adenocarcinoma, Endometrial Endometrioid Adenocarcinoma, Variant With Squamous Differentiation, Endometrial Serous Adenocarcinoma, Endometrioid Stromal Sarcoma, Recurrent Uterine Corpus Carcinoma
Delaware Valley sites
- Abington Memorial Hospital · Abington, PA · Montgomery County
First posted
Registry updated
Added to the directory